Conference/Events
|
Biotech Analyst Chen and… ShowHide Related Items >><< - 04/17/23
- Kura reports preclinical data on use of farnesyl transferase inhibitors
- 02/09/23
- Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib
- 01/24/23
- Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806
- 01/24/23
- Kura Oncology announces FDA clearance of IND application for KO-2806
- 05/08/23
- Syndax reaffirms FY23 research and development expenses view $160M-$175M
- 05/08/23
- Syndax sees Q2 research and development expenses $38M-$43M
- 03/15/23
- Syndax's revumenib shows positive results in two publications
- 02/28/23
- Syndax sees Q1 operating expenses $40M-$45M
- 05/01/23
- Biomea says FDA clearance of IND application to begin Phase I trial of BMF-500
- 04/19/23
- Biomea Fusion to present late breaking data from Phase II trial, COVALENT-111
- 03/28/23
- Biomea Fusion trading resumes
- 03/28/23
- Biomea Fusion trading halted, volatility trading pause
- 07:40 Today
- Aptose Biosciences effects 15-to-1 reverse stock split
- 03/10/23
- Aptose Biosciences says immaterial financial exposure to Silicon Valley Bank
- 01/30/23
- Aptose Biosciences initiates dosing of tuspetinib in APTIVATE expansion trial
- 12/12/22
- Aptose Biosciences establishes at-the-market facility
- 06/03/23
- Affimed presents data on AFM24, continuation criteria for the cohort 'not met'
- 05/25/23
- Affimed to present AFM24-101 data on NSCLC and CRC trial cohorts at ASCO
- 05/23/23
- Affimed receives IND clearance for Phase 2 trial of AFM13, AB-101 combination
- 05/11/23
- Affimed announces abstracts at annual meeting of EHA
CRVS Corvus Pharmaceuticals - 05/17/23
- Corvus Pharmaceuticals to present new CPI-818 data at ICML meeting
- 04/17/23
- Corvus Pharmaceuticals presents new data for CPI-818
- 04/03/23
- Corvus Pharmaceuticals announces interim data on CPI-818
- 02/21/23
- Corvus Pharmaceuticals announces new data on CPI-818
- 05/11/23
- ALX Oncology expects cash to fund operations through mid-2025
- 05/09/23
- ALX Oncology announces first patient dosed in Phase 2 trial of evorpacept
- 04/25/23
- ALX Oncology enters clinical trial collaboration with Sanofi
- 03/13/23
- ALX Oncology, Quantum Leap dose first patient in I-SPY-P1 trial
- 02/14/23
- Indaptus Therapeutics names Martell to board of directors
- 12/12/22
- Curis announces clinical data from TakeAim Leukemia Study of emavusertib
ONCT Oncternal Therapeutics - 04/03/23
- Oncternal Therapeutics falls 41% to 46c per share after drug development halt
- 04/03/23
- Oncternal Therapeutics trading resumes
- 04/03/23
- Oncternal Therapeutics to resume trading at 4:30pm ET
- 04/03/23
- Oncternal Therapeutics halts development of zilovertamab, ibrutinib combination
- 05/25/23
- Sellas Life Sciences to present data from phase 3 REGAL trial of GPS in AML
- 05/04/23
- Sellas Life Sciences announces data from GFH009 Phase 1 dose-escalation trial
- 04/20/23
- Sellas Life Sciences completes Phase I trial dose escalation of GFH009
- 04/18/23
- Sellas Life Sciences IDMC recommends REGAL trial continue as planned
- 04/19/23
- Vincerx Pharma presents preclinical data on VIP924
- 04/17/23
- Vincerx Pharma presents preclinical data on SMDCs at AACR
- 04/17/23
- Vincerx Pharma presents preclincal data on VIP236
- 03/10/23
- Vincerx Pharma says it does not hold deposits, securities at Silicon Valley Bank
- 05/31/23 Barclays
- Barclays reveals two small cap ideas into ASCO conference
- 05/16/23 BTIG
- Kura Oncology initiated with a Buy at BTIG
- 05/11/23 Stifel
- Kura Oncology price target lowered to $24 from $25 at Stifel
- 04/17/23 H.C. Wainwright
- Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright
- 05/11/23 Stifel
- Kura Oncology price target lowered to $24 from $25 at Stifel
- 05/10/23 Citi
- Syndax price target lowered to $31 from $32 at Citi
- 05/09/23 H.C. Wainwright
- Syndax price target raised to $36 from $33 at H.C. Wainwright
- 03/02/23 Citi
- Syndax price target raised to $32 from $29 at Citi
- 05/25/23 EF Hutton
- Biomea Fusion assumed with a Buy at EF Hutton
- 05/18/23 Citi
- Biomea Fusion price target lowered to $53 from $55 at Citi
- 05/12/23 Barclays
- Biomea Fusion initiated with an Overweight at Barclays
- 04/19/23 H.C. Wainwright
- Biomea Fusion price target lowered to $37 from $44 at H.C. Wainwright
- 03/27/23 Canaccord
- Aptose Biosciences price target lowered to $8 from $13 at Canaccord
- 08/03/22 Cantor Fitzgerald
- Aptose Biosciences price target lowered to $6 from $10 at Cantor Fitzgerald
- 09:24 Today H.C. Wainwright
- Affimed price target lowered to $5 from $6 at H.C. Wainwright
- 03/27/23 Wells Fargo
- Affimed assumed with an Overweight at Wells Fargo
- 03/24/23 Stifel
- Affimed price target lowered to $1 from $2 at Stifel
- 12/12/22 Truist
- Affimed price target lowered to $8 from $12 at Truist
CRVS Corvus Pharmaceuticals - 05/30/23 Ladenburg
- Corvus Pharmaceuticals price target raised to $10 from $4 at Ladenburg
- 05/09/23 Cantor Fitzgerald
- Corvus Pharmaceuticals price target raised to $4 from $2 at Cantor Fitzgerald
- 10/07/22 Ladenburg
- Corvus Pharmaceuticals initiated with a Buy at Ladenburg
- 08/09/22 Cantor Fitzgerald
- Corvus Pharmaceuticals price target lowered to $4 from $8 at Cantor Fitzgerald
- 03/14/23 UBS
- ALX Oncology price target lowered to $29 from $31 at UBS
- 03/10/23 H.C. Wainwright
- ALX Oncology price target lowered to $30 from $65 at H.C. Wainwright
- 11/09/22 Cantor Fitzgerald
- ALX Oncology price target lowered to $22 from $32 at Cantor Fitzgerald
- 11/09/22 H.C. Wainwright
- ALX Oncology price target lowered to $65 from $80 at H.C. Wainwright
ONCT Oncternal Therapeutics - 04/06/23 Cantor Fitzgerald
- Oncternal downgraded to Neutral from Overweight at Cantor Fitzgerald
- 04/04/23 Maxim
- Oncternal Therapeutics downgraded to Hold from Buy at Maxim
- 04/04/23 Cantor Fitzgerald
- Oncternal Therapeutics price target lowered to $1.30 from $4.00 at Cantor Fitzgerald
- 04/04/23 H.C. Wainwright
- Oncternal Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 11/15/22 Alliance Global Partners
- Sellas Life Sciences price target lowered to $8 from $14 at Alliance Global
- 06/28/22 Cantor Fitzgerald
- Sellas Life Sciences price target lowered to $6 from $10 at Cantor Fitzgerald
- 11/16/22 Chardan
- Vincerx Pharma price target lowered to $3 from $4 at Chardan
- 06/08/22 Cantor Fitzgerald
- Vincerx Pharma price target lowered to $8 from $22 at Cantor Fitzgerald
- 06/07/22 B. Riley
- Vincerx Pharma price target lowered to $6 from $12 at B. Riley
- 06/07/22 Chardan
- Vincerx Pharma price target lowered to $4 from $11 at Chardan
- 02/23/23
- Kura Oncology reports Q4 EPS (49c), consensus (57c)
- 05/08/23
- Syndax reports Q1 EPS (59c), consensus (60c)
- 02/28/23
- Syndax reports Q4 EPS (62c), consensus (65c)
- 05/02/23
- Biomea Fusion reports Q1 EPS (98c), consensus (81c)
- 03/28/23
- Biomea Fusion reports Q4 EPS (21c), consensus (81c)
- 05/08/23
- Aptose Biosciences reports Q1 EPS (15c), consensus (12c)
- 03/23/23
- Aptose Biosciences reports Q4 EPS (11c), consensus (11c)
- 05/23/23
- Affimed reports Q1 EPS EUR(0.21) vs. EUR(0.14) last year
CRVS Corvus Pharmaceuticals - 05/08/23
- Corvus Pharmaceuticals reports Q1 EPS (17c), consensus (16c)
- 05/11/23
- ALX Oncology reports Q1 EPS (74c), consensus (80c)
- 05/04/23
- Curis reports Q1 EPS (12c), consensus (10c)
- 03/13/23
- Curis reports Q4 EPS (12c), consensus (13c)
ONCT Oncternal Therapeutics - 05/04/23
- Oncternal Therapeutics reports Q1 EPS (20c), consensus (20c)
- 05/11/23
- Sellas Life Sciences reports Q1 EPS (47c), consensus (29c)
- 05/11/23
- Vincerx Pharma reports Q1 EPS (68c), consensus (52c)
|
Hot Stocks
|
Says Standby feature lets… ShowHide Related Items >><< - 13:32 Today
- Apple unveils Journal feature, a new iOS 17 app
- 13:30 Today
- Apple unveils enhanced Autocorrect features
- 13:28 Today
- Apple announces NameDrop, a contact swap feature
- 13:23 Today
- Apple unveils iOS 17 with updated Phone, FaceTime apps
- 08:43 Today Wedbush
- Wedbush expects another 'flex the muscles moment' from Apple at WWDC
- 07:03 Today BofA
- Apple price target raised to $190 from $176 at BofA
- 05:18 Today Evercore ISI
- Apple price target raised to $210 from $190 at Evercore ISI
- 06/02/23 Morgan Stanley
- Apple price target raised to $190 from $185 at Morgan Stanley
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 05/04/23
- Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple reports Q2 EPS $1.52, consensus $1.43
- 06:05 Today
- Apple set to launch VR headset Monday, WSJ reports
- 06/02/23
- Foxocnn to make 20M iPhones a year in Karnataka, DigiTimes reports
- 06/01/23
- Apple customers struggle to get money out of Goldman savings account, WSJ says
- 06/01/23
- Apple targets 50 new or rebuilt retail stores through 2027, Bloomberg says
- 12:00 Today
- What You Missed On Wall Street This Morning
- 09:03 Today
- Fly Intel: Pre-market Movers
- 06/02/23
- What You Missed On Wall Street This Morning
- 06/01/23
- What You Missed On Wall Street On Thursday
- 08:55 Today
- Notable open interest changes for June 5th
- 06/02/23
- Notable open interest changes for June 2nd
- 06/01/23
- Notable open interest changes for June 1st
- 05/31/23
- Apple call volume above normal and directionally bullish
|
Hot Stocks
| ShowHide Related Items >><< - 05/26/23
- Titan Medical enters $7.5M upfront license agreement with Intuitive Surgical
- 06/01/23
- Medtronic names Ken Washington new Chief Technology and Innovation Officer
- 05/25/23
- Medtronic to acquire EOFlow for $738M
- 05/25/23
- Medtronic increases quarterly dividend to 69c per share
- 05/21/23
- Medtronic announces follow-up results of investigational EV ICD system
- 05/30/23 Morgan Stanley
- Medtronic assumed with Overweight from Equal Weight at Morgan Stanley
- 05/26/23 Truist
- Medtronic price target lowered to $90 from $93 at Truist
- 05/26/23 Stifel
- Medtronic price target raised to $92 from $90 at Stifel
- 05/26/23 Bernstein
- Medtronic price target lowered to $99 from $100 at Bernstein
- 05/25/23
- Medtronic sees FY24 EPS $5.00-$5.10, consensus $5.20
- 05/25/23
- Medtronic reports Q4 EPS $1.57, consensus $1.56
- 02/21/23
- Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58
- 02/21/23
- Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30
- 05/10/23
- New suitors showing interest in ShockWave Medical, Street Insider says
- 03/29/23
- ICU teams with Linden Capital for Medtronic assets bid, Reuters reports
- 02/22/23
- Apple hits breakthroughs in glucose monitoring project, Bloomberg reports
- 02/08/23
- Apple names Medtronic's Surface as Chief People Officer, Bloomberg says
- 05/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/25/23
- What You Missed On Wall Street On Thursday
- 05/25/23
- What You Missed On Wall Street This Morning
- 04/28/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 05/25/23
- Unusually active option classes on open May 25th
- 04/24/23
- Early notable gainers among liquid option names on April 24th
- 04/24/23
- Unusually active option classes on open April 24th
- 02/09/23
- Medtronic put volume heavy and directionally bearish
|
Conference/Events
| ShowHide Related Items >><< - 05/18/23
- Boot Barn falls -12.0%
- 05/18/23
- Boot Barn falls -10.8%
- 05/18/23
- Boot Barn falls -9.6%
- 05/17/23
- Boot Barn falls 16% to $63 per share after Q4 results, below-consensus guidance
- 05/18/23 Piper Sandler
- Boot Barn shares look 'remarkably cheap' after miss, says Piper Sandler
- 05/18/23 Craig-Hallum
- Boot Barn price target lowered to $89 from $100 at Craig-Hallum
- 05/18/23 BTIG
- Boot Barn price target lowered to $90 from $107 at BTIG
- 05/18/23 BofA
- Boot Barn price target lowered to $80 from $85 at BofA
- 05/17/23
- Boot Barn sees FY24 EPS $4.70-$5.00, consensus $5.80
- 05/17/23
- Boot Barn sees Q1 EPS 79c-85c, consensus $1.17
- 05/17/23
- Boot Barn reports Q4 EPS $1.53, consensus $1.43
- 01/25/23
- Boot Barn reports Q3 SSS down 3.6%
- 03/04/23
- Cowboy chic is hot, Boot Barn no passing fad, Barron's says
- 05/18/23
- What You Missed On Wall Street On Thursday
- 05/18/23
- What You Missed On Wall Street This Morning
- 05/18/23
- Fly Intel: Pre-market Movers
- 05/17/23
- Fly Intel: After-Hours Movers
|
Hot Stocks
|
Says Journal lets iPhone… ShowHide Related Items >><< - 13:30 Today
- Apple unveils enhanced Autocorrect features
- 13:28 Today
- Apple announces NameDrop, a contact swap feature
- 13:23 Today
- Apple unveils iOS 17 with updated Phone, FaceTime apps
- 13:19 Today
- Apple unveils MacBook Air, 'the world's best 15-inch laptop'
- 08:43 Today Wedbush
- Wedbush expects another 'flex the muscles moment' from Apple at WWDC
- 07:03 Today BofA
- Apple price target raised to $190 from $176 at BofA
- 05:18 Today Evercore ISI
- Apple price target raised to $210 from $190 at Evercore ISI
- 06/02/23 Morgan Stanley
- Apple price target raised to $190 from $185 at Morgan Stanley
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 05/04/23
- Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple reports Q2 EPS $1.52, consensus $1.43
- 06:05 Today
- Apple set to launch VR headset Monday, WSJ reports
- 06/02/23
- Foxocnn to make 20M iPhones a year in Karnataka, DigiTimes reports
- 06/01/23
- Apple customers struggle to get money out of Goldman savings account, WSJ says
- 06/01/23
- Apple targets 50 new or rebuilt retail stores through 2027, Bloomberg says
- 12:00 Today
- What You Missed On Wall Street This Morning
- 09:03 Today
- Fly Intel: Pre-market Movers
- 06/02/23
- What You Missed On Wall Street This Morning
- 06/01/23
- What You Missed On Wall Street On Thursday
- 08:55 Today
- Notable open interest changes for June 5th
- 06/02/23
- Notable open interest changes for June 2nd
- 06/01/23
- Notable open interest changes for June 1st
- 05/31/23
- Apple call volume above normal and directionally bullish
|
Earnings
| ShowHide Related Items >><< - 13:26 Today
- Notable companies reporting after market close
- 05/22/23
- GitLab launches GitLab 16
- 04/18/23
- GitLab, Oracle expand strategic collaboration
- 03/15/23
- GV 2021 GP increases GitLab stake by $19M
- 13:26 Today
- Notable companies reporting after market close
- 03/30/23
- Sprinklr rises 16.6%
- 03/30/23
- Sprinklr rises 13.7%
- 03/30/23
- Sprinklr rises 19.5%
- 05/09/23 DA Davidson
- GitLab initiated with a Neutral at DA Davidson
- 03/29/23 SMBC Nikko
- GitLab initiated with a Neutral at SMBC Nikko
- 03/28/23 Mizuho
- GitLab initiated with a Neutral at Mizuho
- 03/15/23 Barclays
- GitLab price target lowered to $45 from $65 at Barclays
- 03/30/23 Stifel
- Sprinklr price target raised to $13 from $8 at Stifel
- 03/30/23 BTIG
- Sprinklr price target raised to $16 from $12 at BTIG
- 03/30/23 JMP Securities
- Sprinklr price target raised to $20 from $16 at JMP Securities
- 02/15/23 Barclays
- Sprinklr price target raised to $13 from $10 at Barclays
- 03/13/23
- GitLab sees FY24 EPS (29c)-(24c), consensus (52c)
- 03/13/23
- GitLab sees Q1 EPS (15c)-(14c), consensus (16c)
- 03/13/23
- GitLab reports Q4 EPS (3c), consensus (14c)
- 12/05/22
- GitLab sees FY23 EPS (56c)-(54c), consensus (65c)
- 03/29/23
- Sprinklr sees FY24 EPS 13c-15c, consensus 10c
- 03/29/23
- Sprinklr sees Q1 EPS 0c-1c, consensus 2c
- 03/29/23
- Sprinklr reports Q4 EPS 6c, consensus 2c
- 12/06/22
- Sprinklr raises FY23 EPS view to (5c)-(4c) from (8c)-(6c), consensus (7c)
- 05/10/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/02/23
- Sell these stocks now, proven algorithm says
- 03/24/23
- Sell these stocks now, proven algorithm says
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/30/23
- What You Missed On Wall Street On Thursday
- 03/30/23
- What You Missed On Wall Street This Morning
- 03/30/23
- Fly Intel: Pre-market Movers
- 03/29/23
- Fly Intel: After-Hours Movers
- 13:04 Today
- Gitlab options imply 18.3% move in share price post-earnings
- 09:40 Today
- Unusually active option classes on open June 5th
- 05/15/23
- Gitlab call volume above normal and directionally bullish
- 05/09/23
- Gitlab call volume above normal and directionally bullish
|
Hot Stocks
|
Says updated Autocorrect… ShowHide Related Items >><< - 13:28 Today
- Apple announces NameDrop, a contact swap feature
- 13:23 Today
- Apple unveils iOS 17 with updated Phone, FaceTime apps
- 13:19 Today
- Apple unveils MacBook Air, 'the world's best 15-inch laptop'
- 13:19 Today
- Apple unveils new Mac Studio, brings Apple silicon to Mac Pro
- 08:43 Today Wedbush
- Wedbush expects another 'flex the muscles moment' from Apple at WWDC
- 07:03 Today BofA
- Apple price target raised to $190 from $176 at BofA
- 05:18 Today Evercore ISI
- Apple price target raised to $210 from $190 at Evercore ISI
- 06/02/23 Morgan Stanley
- Apple price target raised to $190 from $185 at Morgan Stanley
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 05/04/23
- Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple reports Q2 EPS $1.52, consensus $1.43
- 06:05 Today
- Apple set to launch VR headset Monday, WSJ reports
- 06/02/23
- Foxocnn to make 20M iPhones a year in Karnataka, DigiTimes reports
- 06/01/23
- Apple customers struggle to get money out of Goldman savings account, WSJ says
- 06/01/23
- Apple targets 50 new or rebuilt retail stores through 2027, Bloomberg says
- 12:00 Today
- What You Missed On Wall Street This Morning
- 09:03 Today
- Fly Intel: Pre-market Movers
- 06/02/23
- What You Missed On Wall Street This Morning
- 06/01/23
- What You Missed On Wall Street On Thursday
- 08:55 Today
- Notable open interest changes for June 5th
- 06/02/23
- Notable open interest changes for June 2nd
- 06/01/23
- Notable open interest changes for June 1st
- 05/31/23
- Apple call volume above normal and directionally bullish
|
Hot Stocks
|
Says feature allows users… ShowHide Related Items >><< - 13:23 Today
- Apple unveils iOS 17 with updated Phone, FaceTime apps
- 13:19 Today
- Apple unveils MacBook Air, 'the world's best 15-inch laptop'
- 13:19 Today
- Apple unveils new Mac Studio, brings Apple silicon to Mac Pro
- 13:18 Today
- Apple introduces M2 Ultra
- 08:43 Today Wedbush
- Wedbush expects another 'flex the muscles moment' from Apple at WWDC
- 07:03 Today BofA
- Apple price target raised to $190 from $176 at BofA
- 05:18 Today Evercore ISI
- Apple price target raised to $210 from $190 at Evercore ISI
- 06/02/23 Morgan Stanley
- Apple price target raised to $190 from $185 at Morgan Stanley
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 05/04/23
- Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple reports Q2 EPS $1.52, consensus $1.43
- 06:05 Today
- Apple set to launch VR headset Monday, WSJ reports
- 06/02/23
- Foxocnn to make 20M iPhones a year in Karnataka, DigiTimes reports
- 06/01/23
- Apple customers struggle to get money out of Goldman savings account, WSJ says
- 06/01/23
- Apple targets 50 new or rebuilt retail stores through 2027, Bloomberg says
- 12:00 Today
- What You Missed On Wall Street This Morning
- 09:03 Today
- Fly Intel: Pre-market Movers
- 06/02/23
- What You Missed On Wall Street This Morning
- 06/01/23
- What You Missed On Wall Street On Thursday
- 08:55 Today
- Notable open interest changes for June 5th
- 06/02/23
- Notable open interest changes for June 2nd
- 06/01/23
- Notable open interest changes for June 1st
- 05/31/23
- Apple call volume above normal and directionally bullish
|
Earnings
| ShowHide Related Items >><< - 04/28/23
- J.M. Smucker completes divestiture of several pet food brands to Post Holdings
- 04/28/23
- Post Holdings completes acquisition of pet food brands from J.M. Smucker
- 03/07/23
- J.M. Smucker names Gail Hollander as Chief Marketing Officer
- 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 05/10/23
- MOX Networks deploys Ciena's WaveLogic 5 Extreme
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 04/27/23
- Academy Sports announces planned leadership succession
- 04/25/23
- Academy Sports to open first location in Peoria, Illinois in summer 2023
- 03/02/23
- Academy Sports increases quarterly cash dividend 20% to 9c per share
- 01/11/23
- Academy Sports to open first location in Lafayette, Indiana this spring
- 05/31/23 UBS
- J.M. Smucker price target lowered to $157 from $159 at UBS
- 05/18/23 Deutsche Bank
- J.M. Smucker price target lowered to $158 from $159 at Deutsche Bank
- 05/02/23 Barclays
- J.M. Smucker reinstated with an Equal Weight at Barclays
- 05/02/23 Barclays
- Post Holdings reinstated with an Overweight at Barclays
- 04/06/23 BofA
- Lumentum price target lowered to $56 from $70 at BofA
- 04/06/23 Stifel
- Lumentum price target lowered to $67 from $78 at Stifel
- 04/06/23 Raymond James
- Lumentum price target lowered to $73 from $84 at Raymond James
- 04/06/23 Rosenblatt
- Lumentum downgraded to Neutral from Buy at Rosenblatt
- 08:09 Today JPMorgan
- Academy Sports price target lowered to $61 from $70 at JPMorgan
- 05/24/23 Loop Capital
- Dick's Sporting price target lowered to $135 from $150 at Loop Capital
- 05/01/23 Guggenheim
- Academy Sports price target raised to $73 from $70 at Guggenheim
- 04/28/23 Gordon Haskett
- Gordon Haskett starts 'compelling growth story' Academy Sports at Accumulate
- 02/28/23
- J.M. Smucker revises FY23 adjusted EPS view to $8.55-$8.75 from $8.35-$8.75
- 02/28/23
- J.M. Smucker revises FY23 adjusted EPS view to $8.55-$8.75 from $8.35-$8.75
- 02/28/23
- J.M. Smucker reports Q3 adjusted EPS $2.21, consensus $2.12
- 02/27/23
- Notable companies reporting before tomorrow's open
- 04/06/23
- Ciena reaffirms 2023 outlook and previous demand statements
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 04/04/23
- Academy Sports backs FY23 adjusted EPS view $7.00-$7.75, consensus $7.64
- 03/16/23
- Academy Sports sees FY23 adjusted EPS $7.00-$7.75, consensus $7.65
- 03/16/23
- Academy Sports reports Q4 adjusted EPS $2.04, consensus $1.81
- 12/07/22
- Academy Sports raises FY22 adjusted EPS view to $7.50-$7.40 from $6.75-$7.50
- 05/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/27/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/28/23
- What You Missed On Wall Street On Tuesday
- 02/28/23
- What You Missed On Wall Street This Morning
- 04/06/23
- What You Missed On Wall Street On Thursday
- 04/06/23
- What You Missed On Wall Street This Morning
- 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
- 04/04/23
- What You Missed On Wall Street On Tuesday
- 03/22/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/16/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/06/23
- Unusually active option classes on open March 6th
- 12/08/22
- Unusually active option classes on open December 8th
- 05/01/23
- Academy Sports and Outdoors put volume heavy and directionally bearish
- 12/06/22
- Academy Sports and Outdoors put volume heavy and directionally bearish
|
Hot Stocks
| ShowHide Related Items >><< - 05/22/23
- GitLab launches GitLab 16
- 04/18/23
- GitLab, Oracle expand strategic collaboration
- 03/15/23
- GV 2021 GP increases GitLab stake by $19M
- 03/13/23
- GitLab falls 36% to $28.53 after Q4 results and guidance
- 03/30/23
- Sprinklr rises 16.6%
- 03/30/23
- Sprinklr rises 13.7%
- 03/30/23
- Sprinklr rises 19.5%
- 03/29/23
- Sprinklr jumps 15% to $12.47 after Q4 earnings beat, above-consensus FY23 view
- 05/09/23 DA Davidson
- GitLab initiated with a Neutral at DA Davidson
- 03/29/23 SMBC Nikko
- GitLab initiated with a Neutral at SMBC Nikko
- 03/28/23 Mizuho
- GitLab initiated with a Neutral at Mizuho
- 03/15/23 Barclays
- GitLab price target lowered to $45 from $65 at Barclays
- 03/30/23 Stifel
- Sprinklr price target raised to $13 from $8 at Stifel
- 03/30/23 BTIG
- Sprinklr price target raised to $16 from $12 at BTIG
- 03/30/23 JMP Securities
- Sprinklr price target raised to $20 from $16 at JMP Securities
- 02/15/23 Barclays
- Sprinklr price target raised to $13 from $10 at Barclays
- 03/13/23
- GitLab sees FY24 EPS (29c)-(24c), consensus (52c)
- 03/13/23
- GitLab sees Q1 EPS (15c)-(14c), consensus (16c)
- 03/13/23
- GitLab reports Q4 EPS (3c), consensus (14c)
- 12/05/22
- GitLab sees FY23 EPS (56c)-(54c), consensus (65c)
- 03/29/23
- Sprinklr sees FY24 EPS 13c-15c, consensus 10c
- 03/29/23
- Sprinklr sees Q1 EPS 0c-1c, consensus 2c
- 03/29/23
- Sprinklr reports Q4 EPS 6c, consensus 2c
- 12/06/22
- Sprinklr raises FY23 EPS view to (5c)-(4c) from (8c)-(6c), consensus (7c)
- 05/10/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/02/23
- Sell these stocks now, proven algorithm says
- 03/24/23
- Sell these stocks now, proven algorithm says
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/30/23
- What You Missed On Wall Street On Thursday
- 03/30/23
- What You Missed On Wall Street This Morning
- 03/30/23
- Fly Intel: Pre-market Movers
- 03/29/23
- Fly Intel: After-Hours Movers
- 13:04 Today
- Gitlab options imply 18.3% move in share price post-earnings
- 09:40 Today
- Unusually active option classes on open June 5th
- 05/15/23
- Gitlab call volume above normal and directionally bullish
- 05/09/23
- Gitlab call volume above normal and directionally bullish
|